文献速递介入外周血管骨肌DSA

让我们平息争议——明胶海绵是一种安全的血管内栓塞剂

Let us settle the controversy-gelfoam is a safe intravascular embolic agent.
PubMed 文献 · Br J Radiol · 2024-01-01

本研究为回顾性队列研究,纳入2010年1月1日至2021年5月21日期间因骨盆动脉出血接受明胶海绵栓塞的50例创伤患者,评估血管内明胶海绵给药相关不良事件发生率。结果显示明胶海绵相关并发症为0例,技术成功率100%,全因死亡5例(10%)与明胶海绵无关;作者结论为明胶海绵在骨盆创伤中是安全有效的栓塞剂。

要点

  • 骨盆创伤动脉出血行明胶海绵栓塞,本组50例中明胶海绵相关并发症为0例。
  • 本组技术成功率为100%,35例(70%)采用非靶向栓塞方式。
  • 全因死亡5例(10%),原文明确与明胶海绵无关。

核心结论

  • 明胶海绵在骨盆创伤中是安全有效的栓塞剂,创伤后大出血中可挽救生命,患者亟需血管内明胶海绵产品的通用标签注册。

研究设计与样本

  • 回顾性队列研究,纳入2010年1月1日至2021年5月21日期间因骨盆动脉出血接受明胶海绵栓塞的患者,共50例。

诊断标准与关键数值

  • 主要结局为血管内明胶海绵给药相关不良事件发生率,本组为0例;技术成功率为100%。

临床应用与阅片要点

  • 作者认为血管内明胶海绵是高质量创伤服务所必需的,本研究显示有意在血管内空间使用是安全的;企业应与介入放射科医生合作,共享并协作以确保患者获得良好结局。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: A 2021 safety alert restricted endovascular gelfoam use in Australia and resulted in an embargo on gelfoam sales to Interventional Radiology departments. This study aimed to show that gelfoam is safe in a population of trauma patients with pelvic injury, and discuss the basis of the recent controversies.

METHODS: Retrospective cohort study was conducted between 1 January 2010 and 21 May 2021 for the patients who underwent gelfoam embolization for pelvic arterial haemorrhage. Primary outcome was the rate of adverse events related to intravascular gelfoam administration.

RESULTS: Inclusion criteria met in 50 patients, comprising 58% males median age 59.9 years, and median injury severity score 31. There were 0 complications related to gelfoam use and 100% technical success. Thirty-five patients (70%) received a non-targeted embolization approach. All-cause mortality was observed in 5 patients (10%), unrelated to gelfoam.

CONCLUSIONS: Gelfoam is a safe and effective embolic agent in pelvic trauma. Patients are in urgent need of universal on-label registration of endovascular gelfoam products, as it is life-saving in major haemorrhage after trauma.

ADVANCES IN KNOWLEDGE: Endovascular gelfoam is mandatory for a high-quality trauma service, and this study shows that it is safe to use intentionally in the endovascular space. Companies should work with interventional radiologists, sharing and collaborating to ensure positive outcomes for patients.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Clements W, Lukies M, Zia A, et al. Let us settle the controversy-gelfoam is a safe intravascular embolic agent. Br J Radiol. 2024. PMID: 38402518. doi:10.1093/bjr/tqae047

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。